Ledger.Open graph →
SEC Form D · Amendment · filed March 27, 2018

Taiga Biotechnologies, Inc

Offering
$20.0M
Sold
$8.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Stephen K. Erkenbrack · Aurora, CODirectorJames C. Kelly · Aurora, CODirectorEarl L. Wright · Aurora, CODirectorYosef L. Refaeli · Aurora, COExec · DirectorBrian C. Turner · Aurora, COExec · DirectorDaniel L. Ritchie · Aurora, CODirectorJasvir Kaloti · Vancouver, British Columbia, CanadaDirectorRoger L. Fidler · Lutz, FLDirectorJerry Kochanski · Summit, NJExec · DirectorJerry Kochanski · Relationship(s): Executive Off, NJExec · DirectorJinhua L. Guo · Hebei, IsraelDirectorGreg Fleishman · Pacific Palisades, CADirectorChristopher Biasotti · New York, NYDirectorEmily Deboer · Denver, COExec · DirectorRobin Deterding · Boulder, COExec · DirectorJeremy Prager · Englewood, CODirectorPatrick O. Ingle · GAINESVILLE, FLDirectorAngelo Luis · Luxembourg, LuxembourgDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗